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Chapter I: Introduction
A- Background
On average, comprehensive orthodontic treatments last approximately 21-27 months in
non-extraction cases and 25-35 months when extractions are considered in the treatment
plan. [1] Longer treatment time has been associated with multiple detrimental effects such as
white spot lesions [2], root resorption [3], gingival inflammation [4] and dental caries.
Additionally, increased treatment time often leads to the exhaustion of the patient’s
compliance. It is then in the patient’s and in the clinician’s interest to identify methods to
increase the speed and efficiency of treatment. It has been estimated that normal tooth
movement occurs at a rate of 0.8-1.2 mm/month. [1] As yet, research has focused on three
main modalities to enhance the rate of tooth movement: pharmacological, surgical and
mechanical approaches. Local or systemic administration of biological factors such as
parathyroid hormone (PTH), thyroxine, Vitamin D3 and prostaglandins have been
investigated in various experiments and have been found to increase the velocity of tooth
movement. However, using these approaches has also shown some systemic adverse effects,
such as pain and severe root resorption. Some surgical techniques such as osteotomy,
corticotomy, corticision and piezocision have shown possible increases of orthodontic tooth
movement by taking advantage of the Regional Acceleratory Phenomenon. However, due to
its invasive nature, patients are less inclined to consent to this method. Furthermore,
numerous studies have demonstrated the short term effect of this RAP phenomenon, lasting
on average only 2-4 weeks. Finally, the application of mechanical vibration to the dentition
has also been hypothesized to increase the rate of tooth movement by affecting the
expression of key biological factors involved in bone remodeling.

The application of orthodontic forces results in remodeling of the alveolar bone through
activity of important cells such as osteoblasts and osteoclasts. A number of key factors have
been shown to activate osteoclastogenesis, the RANK/RANKL/OPG signaling pathway
being one of them. RANKL is a molecular biomarker secreted by osteoblasts, responsible for
the recruitment, differentiation and survival of osteoclasts. The binding of RANKL with
RANK (expressed at the surface of the osteoclast) induces the differentiation of the immature
osteoclasts into functional cells. Meanwhile, osteoprotegerin (OPG) is also produced by the
osteoblasts and acts as a soluble receptor for RANKL, inhibiting the terminal stages of
osteoclast differentiation. [5] It serves as a negative feedback maintaining homeostasis
between bone formation and resorption. The role of the OPG/RANKL system in bone
remodeling has been illustrated in several studies performed on animals [6] [7] [8] and
recently on humans during orthodontic treatment. [9]

1- Vibration and Orthodontic Tooth Movement
A patient’s primary concern with fixed orthodontic appliances is the time required for
treatment. Since the development of a vibrating mouthpiece device for orthodontic purposes
in 1982 by Kurz, application of external vibrational force has spawned some interest in
academic literature. [10] Animal studies examining the effect of vibration have shown
potential for an acceleration of tooth movement, stimulating the inflammation process by
possibly altering the periodontal apparatus or by creating osteogenic effects. [11] In a study
performed on rats, Nishimura and colleagues demonstrated that the application of resonance
vibration at 60 Hz, accelerated orthodontic tooth movement via increased expression of
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RANKL in the periodontal ligament. [12] Additionally, pulsed electromagnetic field
vibration delivered eight hours per day on Wistar rats has also shown significantly
accelerated tooth movement. [13] Recently, several studies have demonstrated that the
application of mechanical vibration with low-magnitude and high frequency can enhance
bone remodeling, prevent bone loss, and improve bone healing in animals and humans. [14]
However, the process by which this outcome is seen is not clearly understood. In a study
where vibration was applied to stem cells that had been isolated from extracted premolars,
the collected data demonstrated that mechanical vibration promotes osteogenic
differentiation of human periodontal stem cells and increases osteogenesis markers. [14]

At the clinical level, few randomized clinical trials have been published. In 2009, an
attempt to reproduce vibration delivery in humans was made by the confection of a novel
device named AcceleDent, applying cyclic forces of 25g at a frequency of 30 Hz. In a case
series including 14 patients, Kau et al. noticed a rate of tooth movement of 2.1 mm per month
in the mandibular arch while 3.0 mm was observed in the maxilla, the majority of the results
being measured in terms of reduction of Little’s Index scores. They then concluded this rate
was statistically significantly faster than the usual 1 mm per month of movement reported in
the literature. [15] A randomized clinical trial was then performed by Pavlin et al., assessing
the rate of space closure during canine retraction. The results showed an average monthly
tooth movement rate of 1.16 mm/month when the AcceleDent appliance was used for 20
minutes daily, corresponding to an increase of 48% in the rate of space closure. [16] Shortly
thereafter, another RCT was performed by an Australian group of authors using a slightly
different vibration device. Notably, this device called the Tooth Masseuse delivered a
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vibrational force of higher frequency but lower amplitude than the Acceledent device.
Looking at Little’s irregularity index, they concluded there was no statistically significant
difference between control and experimental groups. [17] In a similar protocol, Bowman et al
found an increase rate of leveling and aligning during comprehensive treatment by 30% and
29-40% respectively. [18] Conversely, Woodhouse and colleagues recently conducted a
randomized clinical trial which found no evidence that supplemental vibration added to
conventional orthodontic treatment, increase the rate of initial tooth movement or reduce the
amount of time required to achieve final alignment. [19] Finally, in a recent systematic
review in the Cochrane Library, the authors concluded that the available evidence is of very
low quality and it is not possible to determine if there is a positive effect of vibration device
in conjunction of fixed appliances to accelerate tooth movement. [20] Based on this
evidence, this branch of orthodontics is currently still controversial. There is therefore a clear
need for well-designed clinical trials in order to determine the actual effect of the application
of cyclical forces on the rate of tooth movement.

2- Vibration Treatment- Bone Remodeling Biomarker Measurement
Orthodontic tooth movement results from remodeling of the periodontal ligament and
alveolar bone after the inflammatory process has been initiated. [9] Vibrational loading is
claimed to stimulate bone remodeling; however, the biological mechanism underlying this
effect is not clearly understood. Does it activate the known signaling pathways of tooth
movement or does it activate a new one? Identifying factors that are differently expressed
when orthodontic force is applied could help our profession to fully understand this complex
mechanism and could also guide us toward different target factors in our pursuit of the
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acceleration of the rate of tooth movement. An important marker to illustrate the rate of bone
turnover is the RANKL/OPG ratio and multiple studies have clearly detected these cytokines
during orthodontic tooth movement. [9] [5] More specifically, biological factors can be
categorized in relation to their role in bone formation or bone resorption. The former can be
measured by evaluating the bone formation markers such as alkaline phosphatase (ALP) [21]
and osteocalcin (OC) in saliva, in gingival crevicular fluid and in blood. [22] [23] In a study
performed on rats, Hashimoto et al. have shown an increase in the rate of orthodontic tooth
movement when OC was injected at the bifurcation of the maxillary first molar. [24]
Regarding bone resorption, osteoclast activity can be represented by the breakdown product
of type I collagen such as C-terminal telopeptide (CTX).

Early phase of tooth movement involves an acute inflammatory process accompanied by
vascular vasodilation, immune cell migration as well as secretion of multiple chemical
messengers. Pro-inflammatory cytokines, interleukins and matrix metalloproteinases are also
known to be activated in response to orthodontic treatment. Cytokines are active molecules
that regulate the inflammatory process. When they bind to a cellular receptor, they can
influence diverse biological activities, such as immune function and cellular activation,
proliferation and survival. Tumor Necrosis Factor alpha (TNF-α) and interleukins are
cytokines that have been shown to be increased with orthodontic force application in rats [25]
and humans [26] and to be involved in the induction of osteoclastogenesis. Studies in bone
remodeling have indicated that certain interleukins such as IL-1 [27] [28] [26], IL-6 [29] [30],
IL-8 [31] and IL-17 [32] are important regulators in the bone remodeling process and thus
have shown increased levels during orthodontic force application. For instance, interleukin-
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1β, a protein involved in the mediation of inflammation, has been shown to rise in GCF
within a short time after the application of pressure. [26] [27] Finally, of the inflammatory
mediators that are involved in alveolar bone resorption, matrix metalloproteinases (MMPs)
have been implicated in orthodontic tooth movement. They represent a family of proteases
that play key roles in collagen breakdown and serve as important biomarkers of bone
remodeling. Multiple studies have shown increased expression of certain metalloproteinases
during orthodontic treatment. Among these MMPs, increased levels of MMP-9 were found in
the gingival crevicular fluid in response to external pressure on teeth. [33] [28] [34] [35]
MMP-13 was also highly expressed in the periodontal ligament and alveolar bone early on
following the application of an orthodontic force. [36] [37]

Evaluating the expression of different biomarkers of bone remodeling in patients
undergoing orthodontic treatment in combination with vibration devices could help us clarify
the specific biomechanical pathways engaged when methods of tooth movement acceleration
are used. The test chosen to conduct the assessment must have an acute sensitivity to the
factors of interest and needs to be relatively minimally invasive in order to have a good
acceptance from patients. Multiple methods to assess biological factors have been used in the
literature; blood, gingival crevicular fluid and saliva being some examples. Recently, we have
noted an increased used of saliva analysis in the oral health field. It is claimed to be a mirror
of the body and is used as a diagnostic tool that has many advantages such as its non-invasive
nature, its ease of use and the fact that sufficient quantities can be often easily obtained for
analysis. [38] It has previously been employed in the detection of caries risk, periodontitis,
oral cancer, breast cancer, salivary gland disease, hepatitis, HIV and HCV [39]. In

6

orthodontics, despite that only few studies have been conducted evaluating saliva for the
expression of multiple bone remodeling factors, this newly emerging field shows great
promise.

3- Vibration Treatment- Pain and Quality of Life During Orthodontic Treatment
In addition to the potential increase in rate of tooth movement, it has been hypothesized
that vibration may help in the reduction of dental pain during active orthodontic treatment.
Two randomized clinical trials comparing a control group and an experimental group
obtained contradictory results: one concluded decreased pain when vibration appliance was
used [40] while the other study found no statistically significant difference [17]. Recently,
another study including a sham device group incorporated in the design was published and
supported the previous Australian conclusion with no significant difference found in the pain
level during the week following the placement of fixed appliance and wire insertion [41].

Recent studies have shown that malocclusion is also associated with poor Oral Health
Quality of Life (OHQoL) [42]. However, as yet, the literature does not give conclusive
evidence on the psychosocial effect of orthodontic treatment. In studies performed on a
Brazilian population, they found that patients who received orthodontic treatment (children
as much as adults) had significantly better OHQoL after treatment is completed than
untreated subjects [43] [42]. However, research [44] has also shown that some patients go
through a transitional phase of deterioration of the OHQoL during the active orthodontic
phase. [45] Due to limited literature regarding the effect of orthodontic treatment on OHQoL,
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further research is needed to assess to psychosocial impact as well as the possible factors that
could contribute to improve the overall experience of the patients during treatment.

B- Study Rationale
Currently, orthodontic treatment usually lasts approximately 2 years. There are multiple
advantages for reducing the treatment time; decrease risk of root resorption and
decalcification [46], maintain good periodontal health as well as minimize patient “burn out”
from prolonged treatment.

Some clinical studies using a vibration device in conjunction with fixed appliances have
assessed the acceleration of tooth movement, showing some contradictory results.
Furthermore, a recent systematic review published in the Cochrane Journal has stipulated a
very low level of evidence among these articles [44]. There is thus a clear need of welldesigned clinical studies in order to elucidate the clinical effect of vibration.

Additionally, the biological mechanism during acceleration of the rate of tooth movement
is still unknown. Identification of specific biomarkers in the saliva that may be stimulated by
the use of a vibration device could help the profession to understand the pathways involved
and could lead to new biological factors that could be targeted to achieve the goal to reduce
orthodontic treatment time.
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The aim of this study is to evaluate the effects of vibration on the rate of alignment of the
mandibular anterior teeth and to identify biological factors that are expressed with this
therapy.

Outcome assessment
o Primary outcomes: Changes in the expression of salivary biomarkers of bone
remodeling
o Changes in rate of alignment of lower incisors


Secondary outcomes:
o Changes in tooth mobility
o Changes in pain and Oral Health and Quality of Life

Chapter II: Hypotheses and Aims
A- Hypotheses and General Objectives
1- Hypotheses
1. The expression of specific biomarkers of bone remodeling in saliva is increased
when fixed orthodontic appliances are combined with vibration.
2. The degree of tooth mobility is increased in patients with the combination of fixed
orthodontic appliances and vibration.
3. The rate of incisor alignment is increased when fixed orthodontic appliances are
combined with vibration.
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4. Orthodontic patients using vibration devices daily experience less pain and
improvement in the quality of life compare to those in the control group.

2- General objectives
There is a clear lack of evidence in the orthodontic literature about the effect of a vibration
device on the speed to tooth movement. Additionally, the biological mechanism by which
vibration may increase the rate of tooth movement is still unknown. The primary objective of this
study is to assess the potential influences of vibration device on the expression of biomarkers of
bone remodeling.

B- Specific Aims and Objectives
1- To determine if the addition of vibration to the regular fixed orthodontic appliances can
alter the expression of biologic factors involved in bone remodeling.
2- To further elucidate the role of vibration treatment on the degree of tooth mobility during
fixed appliance treatment compared to control group.
3- To determine if combined vibration-fixed appliance treatment increases the speed of
orthodontic tooth movement during the alignment phase
4- To evaluate the role of vibration treatment in the control of pain and quality of life in
patients undergoing orthodontic treatment.

Chapter III: Materials and Methods
A- Study Design and Screening procedure:
1- Study design
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This study was approved by the Institutional Review Board (IRB) of University of Connecticut
(IRB #14-117-2). The aim of this study was to perform a randomized clinical trial recruiting a
total of 40 patients equally and randomly divided in four groups: (1) 10 male subjects in control
group; (2) 10 male subjects in vibration group; (3) 10 female subjects in control group; (4) 10
male subjects in vibration group.

Male subjects
(N=20)
Orthodontic
patients (>5mm
crowding, nonextraction)
(N=40)
Female subjects
(N=20)

Treatment group
Vibration + Fixed
appliance
treatment group
Control group
Fixed appliance
treatment only
(N=10)
Treatment group
Vibration + Fixed
appliance
treatment group

Control group
Fixed appliance
treatment only
(N=10)

No randomized clinical trials are currently available to predict vibration effects on the expression
of biomarkers. Therefore, this study serves as a pilot research including 40 patients in 4 groups
divided by gender and vibration/no-vibration treatment. This trial was registered in at Clinical
Trials.gov (14-117-2).

2- Screening & Recruitment Procedures
Prospective subjects were screened for this study through the regular screening procedures
followed by all new patients of the orthodontic clinic of University of Connecticut. The provider
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assigned to the patient at the screening appointment determined if the patient was likely to
qualify according to the inclusion/exclusion criteria and advised the study coordinator (MCC) if
the clinical indicators were met. The initial eligibility requirements included any healthy male or
female between 15-35 years old, not taking any medication, with good oral hygiene, with a
minimum of 5 mm incisor crowding requiring a non-extraction treatment. If the prospective
subjects met the initial criteria, the study coordinator then confirmed the possible eligibility by
consulting the screening forms, models and/or radiographs. In a situation where the patient was
between 15-17 years old, the initial provider asked the parent permission to provide the
information to the study coordinator.

3- Enrollment
After the primary provider had determined the possible eligibility of a patient as well as
verified his/her interest to participate in the trial, the study coordinator met with the potential
subject on the next appointment (record appointment). The study was then explained to the
subject in detail and informed consent was obtained by the patient himself and/or the parent (in
the situation that the subject was under 18 years old). The patients had to meet the following
inclusion/exclusion criteria in order to be enrolled in the study:

Inclusion Criteria
Healthy, non-smoker with no systemic medical
conditions and no routine medications
15 to 35 years of age at the time of bonding
Non-extraction treatment plan or no extractions required
in the first 6 months of treatment
At least 5mm of crowding in the mandibular arch
Full-complement dentition 1st molar to 1st molar
Good oral hygiene

Exclusion Criteria
Patients that require extractions as part
orthodontic plan
Smoking or excessive alcohol consumption
Patients with edentulous areas

of

the

Evidence of periodontal disease (any pocket depths
more than 4mm)
Use of anti-inflammatory drugs within 2 days of bonding
Uncontrolled diabetes
Dentofacial deformities (cleft palate, hemifacial
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microsomia, etc.)
Subjects routinely taking any of the following
medications:
Corticosteroids (including for asthma)
Bisphosphonates
Anti-inflammatories
Nicotine Patch
Estrogen
Opioids
Growth Hormone
Relaxin
Anti-coagulants
Diseases that could affect bone metabolism:
Parathyroid or thyroid dysfunction
Osteoporosis, Osteomalacia
Vitamin D deficiency
Fibrous dysplasia
Paget’s Disease
Multiple Myeloma
Osteogenesis Imperfecta
History of Bone Metastasis
Patients taking medications such as bisphosphonates,
corticosteroids or any anti-inflammatory drug

After enrollment, the patients were instructed not to use any anti-inflammatory medications
during the course of the research and to not eat or drink for the duration of an hour prior to the
appointment.

B- Study procedure
1- Standardized Orthodontic Treatment Protocol
The patients enrolled in the study had to follow a standardized protocol in order to
minimize any possible variability that could affect the outcomes. All patients were bonded
with passive self-ligating brackets (Carriere brackets) featuring 0.022”X0.025” slot and MBT
prescription from second premolar to second premolar as well as a bonded tube on first
molars. At the bonding appointment (T0), an 0.014” Cu-NiTi wire was inserted on the lower
arch and was kept until the T2 appointment. At T2, bracket position was assessed by a
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blinded provider and repositioning was performed as instructed by that provider. At this same
appointment, the wire was changed for 0.014”X0.025” Cu-NiTi.

All subjects were seen for orthodontic adjustments every 5-6 weeks. If a bracket
loosened, the patient had 7 days to advise his/her provider and the latter repositioned it to the
ideal position. Failure to follow this protocol led to immediate disqualification from the
study.

2- Randomization Procedure
Block randomization was chosen as the randomization technique for this study. Since
study groups were subdivided by gender, separate randomization was performed for males
and females. Twenty opaque envelops were included in each group (male and female) with
10 for control group and 10 for vibration group. During the bonding appointment (T0), the
subject was asked to pick an envelope and disclose the allocated group. In the scenario of
being assigned to the Acceledent group, instructions were given by the study coordinator
regarding the operation of the device and they were told to use it 20 minutes per day for the
whole study duration (3 months) according the to manufacturer’s instructions.

3- Data Collection Procedure
On the day of bonding, the baseline measurements were taken: unstimulated whole saliva
was collected, Periotest was performed, alginate impression was taken and Oral Health
Quality of Life questionnaire was answered. After fixed appliances were placed, the subjects
were submitted to regular orthodontic treatment with or without the vibration device,
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according to their group allocation. All measurements were taken once again at T1 (5-6
weeks), T2 (10-12 weeks) and T3 (15-18 weeks). Each subjects were seen at approximately
the same time in the day in order to minimize the variables coming from the circadian rythms
followed by salivary biomarkers.



Salivary collection
Collection of unstimulated whole saliva was performed following the same protocol

described by Navazesh and Kumar Quote. The saliva was collected into a sterile tube at
baseline and then at each visit by passive drooling for 15 minutes or until 10 mL was
reached. Proteinase inhibitor (Sigma-Aldrich, proteinase inhibitor cocktail, P2714) was
then added to the accumulated saliva and centrifuged at 6000 rpm for 15 minutes to
remove cellular debris and supernatants. This cocktail was made of AEBSF at 2 mM,
Aprotinin at 0.3 µM, Bestatin at 116 µM, E-64 at 14 µM, Leupeptin at 1 µM and EDTA
at 1 mM. At any time during the collection or the processing, the sample was kept on ice
to assure preservation of the biomarkers. The samples were all stored in a -80ºC until
biomarker analysis.
Biomarkers were assessed with the ELISA assay test using a direct sandwich method and
standard protocol. A sample of primary antibodies with the desired selected factors was
pre-coated on dishes. A secondary conjugated antibody was used to recognize binding
with the use of chemiluminescence on the incubated sample product or standards. The
targeted biomarkers include ALP, RANKL/TRANCE, OPG, Osteocalcin (bone formation
marker), MMP8, MMP13, TNF α, IL1a, IL1b, IL3, IL6, IL11, and IL18. However, until
now, only IL-1 β and IL-8 have been analyzed. Human antibody samples to these target
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biomarkers were supplied by R&D Systems, inc. Furthermore, using a RatLaps kit
(Immunodiagnosis System, Inc), salivary C-terminal telopeptide of type I collagen (CTX)
(an indicator of bone resorption) will also be analyzed in the near future using the ELISA
assay test.



Cast Analysis
Dental casts were assessed by one blinded evaluator to determine the rate of tooth

movement. Each mandibular model was evaluated for the mandibular anterior alignment
from canine to canine, using Little’s irregularity index. This index uses the displacement
of the adjacent anatomic contact points of the mandibular incisors (mesial to right canine
to mesial of left canine) in millimeters and determines the Irregularity Index of the
subject by adding the five measurements together. [47] The measurements were
measured on each model at T0, T1, T2 and T3 with a digital caliper held parallel to the
occlusal plane and was evaluated over the 3 months’ study period.



Periotest Measurement
At each time points, the mobility of specific teeth of lower arch (central incisors,

canines and second premolars) was assess with a device named Periotest (Siemens AG,
Bensheim, Germany) as previously described by Liou et al [48]. The lower wire was
removed and the tip of the device was held parallel to the floor, perpendicular to the tooth
axis and 2 mm away from the labial surface. Each tooth was measured 3 times and the
mean was recorded. The study coordinator located an area on the labial surface that had
sufficient space for the tip to contact the teeth in order to take consistent measurements.
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Teeth were out of occlusion during the recording. The values obtained by the Periotest
can ranged from -8.0 to +50.0 and the unit of measure was “Periotest values”. The scale
correlates with Miller’s index as shown in the table below: [49]

PTV Measure

Indication

-8.0 to +9.9

No movement distinguishable (Miller classification 0)

+10.0 to +19.9

First distinguishable sign of mobility (Miller classification I)

+20.0 to +29.9

Crown deviates within 1 mm of normal position (Miller classification II)

+30.0 to +50.0

Mobility easily noticeable (Miller classification III)



Orthodontic Pain Assessment
Patients were instructed to fill a pain diary at the T0, T1 and T2 appointment to

record the degree of pain experienced during their orthodontic treatment. It was assess
using a Visual Analog Scale (VAS) ranging from 0 (no pain) and 10 (extreme pain) and
was filled during the 7 days following their appointment. The completed diary was
returned at the next appointment and stored by the study coordinator in the study record.



Oral Health Quality of Life (OHQoL)
Patients were asked to complete an Oral Health Impact Profile (OHIP-14)

questionnaire in order to measure subject’s perceptions of the impact of oral conditions
on their well-being as well as the possible impact of vibration device on it. This
questionnaire included 14 questions that were divided into specific categories including
functional limitation, physical pain, psychological discomfort, physical disability, social
17

disability and handicap. Each question was answered on a 5-point scale, ranging from 0
(never) to 4 (very often). The value was then multiplied by the weight attributed to it and
added to the other questions of the same category to give a total score for each subgroup.

C- Statistics
Intrareliability of the irregularity measurements was assessed using the T0 and T3 models
evaluated by the one blinded evaluator for all patients. The reliability of the measurement
was then assessed by the use of Cronbach alpha analysis.
The Mann-Whitney Test was used to assess differences between groups for all the
continuous variables with an α= 0.05 for Periotest measurements, irregularity index changes,
biomarkers concentration, VAS and OHIP-14 measures.
18

A non-parametric analysis was also performed using the Spearman’s rank correlation
coefficient to analyze possible association between salivary biomarkers expression and the
change in the irregularity index.

Chapter IV: Results
Twenty-three patients were enrolled since the start of the project; of these, 11 (3
boys, 8 girls) were allocated to the Acceledent group and 12 (3 boys and 9 girls) were
assigned to the control group. The enrollment started in June 2014 and is still in progress.
Out of the 23 patients recruited, 3 patients of the control group were removed after
enrollment: (see Figure 2): 1 female patient decided to continue her orthodontic treatment
in another clinic, another failed to show at his third appointment and the last one had an
emergency medical procedure which required the administration of anti-inflammatory
drug, requiring exclusion from the study. The mean age of the participants allocated to
the Acceledent and control group at the beginning of the trial was 20.6 and 21.0 years
old, respectively. The initial irregularity means for the fixed appliances only was 9.1 (SD,
3.41) mm while the experimental group showed an average of 8.6 (SD, 3.92) mm, with
no statistically significant different among the groups (P=0.817).

Table I shows the mean irregularity index at each time point for both groups.
There was no statistically significant difference found between the experimental and
control groups (P = 0.817, 0.763, 0.934, 0.544). In terms of the changes in irregularity
over the 3 time points, the data which are represented in Table II did not show significant
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differences for any of these periods (P = 0.900, 0.643, 0.716, 0.713, respectively).
Multivariate linear regression was also performed to assess any potential correlations
between the initial irregularity, age, sex and type of intervention on the reduction of the
irregularity index. The only significant difference appreciated among the groups was
attributed to the gender at T0 and T1, with the female group experiencing statistically
significant less crowding. Also, when looking at the total alignment periods (T0-T3),
there was a significant gender difference with females aligning less than males. In regards
to patient compliance with Acceledent, based on the data recorded by the device, a great
variability was observed in the percentage of use, varying from 2% to 102%, for a mean
compliance rate of 63%. This result is in agreement with the 67% compliance reported by
Kau et al. [15] The intra-reliability test showed excellent consistency with a Cronbach’s
Alpha value of 0.997 and 0.990 for T0 and T3 respectively.

The Visual Analog Scores (VAS) illustrated by the pain diary are represented in
Table III. There was no significant difference in the level of pain intensity between both
groups at T0, T1 and T2 (P = 0.775, 0.685, 0.100).

Table IV-V-VI show the tooth mobility changes collected with the Periotest
device between each appointment. There was no statistically significant difference
between the Acceledent and fixed appliances only groups at any time points. The highest
increase in mobility was recorded between T0 and T1 and when comparing each tooth
type, the highest changes were seen at the level of the incisors.

20

The evolution of OHQoL during orthodontic treatment was assessed using the
Oral Health Impact Profile-14 (see Table VII). The initial results show steady means
from T0 to T1 to finally reaching improved levels lower than the baseline values. There
was no statistically significant difference between groups (P = 0.225, 0.565, 0.406,
0.565).

Up to now, temporal changes in the biomarker levels in the saliva were measured
at each time points for IL-1β, IL-8 and TNF-alpha (see table VIII-IX). Since TNF-alpha
concentration was found below the limits of detection in all samples, no statistical
analysis could be performed. On the other hand, IL-8 and IL-1β were detected by the
ELISA test and these two biomarkers showed no statistically significant difference
between both groups at each time point. Furthermore, no correlation was found between
the biomarkers and the changes in the irregularity index.

Chapter V: Discussion
Historically, comprehensive orthodontic treatment has been claimed to last approximately
21-27 months in non-extraction cases and 25-35 months when teeth are extracted. [1]
Unfortunately, fixed appliance treatment, especially when duration is prolonged, can also
result in harmful consequences such as white spot lesions [2], root resorption [3], gingival
inflammation [4] and dental caries. To this date, research has focused on 3 main modalities to
try and increase the rate of tooth movement and thus decrease the treatment time:
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pharmacological, surgical and mechanical approaches. Although surgical modalities such as
corticision, piezocision and Periodontally Accelerated Osteogenic Orthodontics have shown
some positive data by taking advantage of the so called Regional Acceleratory Phenomenon,
their invasive nature makes patients less inclined to consent to these treatment plans.

Some studies have investigated the effectiveness of the application of vibration during
orthodontic treatment but up to now, no consensus has been made. In our research, no
statistically significant difference between both groups was found either in the mean incisor
irregularity at each appointment or in the changes in irregularity over the 3 time points. This
result is in agreement with Miles et al [17] as well as Woodhouse et al [19] which both found
in their respective study no increase in the rate of tooth movement when a vibration device
was used. On the other hand, Pavlin et al [16] showed in a randomized clinical trial an
average monthly rate of tooth movement of 1.16 mm/month when the AcceleDent appliance
was used for 20 minutes daily, corresponding to an increase of 48% in the rate of space
closure compared to their control group. However, it is primordial to be careful with the
interpretation of their results since their design was slightly different, whereby they assessed
the rate of space closure during canine retraction rather than the incisor alignment.

Pain is a common effect of orthodontic treatment and it is usually more significant
immediately following appliance placement. Studies have shown that pain generally
increases during the first 24 hours after adjustment appointment and then gradually reduces
over a week [50] [51] [52]. In our study, analysis of the visual analogue scale confirmed this
tendency in the level of pain felt by the patients at each time points, being the highest about
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two days after the adjustment appointment and gradually reducing afterward. Other methods
such as analgesic consumption record and questionnaires have also been reported in the
literature to assess pain in orthodontic patients. [52]

Regarding the role of vibration device on pain level, previous studies have shown
contradictory results. Lobre et al showed that the level of discomfort was significantly
reduced by using this method. They mentioned that patients using the Acceledent device had
lower scores for overall pain as well as biting pain during the 4 months’ period of the study.
[40]

Our findings are in disagreement with this previous study, showing no significant
difference when patients were using a vibration device. Miles et al. showed similar results
than us, with no significant difference between the groups in regards to pain at any of the
time points during the study. [17] Furthermore, Woodhouse et al. in 2015 determined that the
only significant predictor for mean pain was the time. Their data also showed that the use of
Acceledent vibrational device did not have any significant effect on the pain level or
analgesic consumption during the initial alignment phase. [19] Even though these two studies
are consistent with our findings, more studies with higher sample sizes are needed to draw a
definite conclusion on the subject. Interestingly enough, even though no significant
difference in the pain experienced by the patient during orthodontic treatment was found in
our study, three patients reported soreness on the teeth at the end of the daily 20 minutes of
vibration, one of them having to stop using the device altogether due to severe pain.
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Regarding the Oral Heath and Quality of Life, the overall scores stayed steady between
the first and the second appointments, ultimately improving thereafter and reaching levels
lower than the baseline values. Similar to the pain level, we did not find any significant
differences between the two groups. These findings are in agreement with previous research
which showed that some patients go through a transitional phase of deterioration of the
OHQoL during the active orthodontic phase [44] [45]. This result might be explained by the
fact that following the bonding appointment, the patient can be self-conscious about the
appearance of the fixed appliances, which would increase the overall score of the Oral Health
Impact Profile (OHIP-14) questionnaire. Furthermore, the lack of a statistically significant
difference found might also be related to the small sample size. Conversely, a study
performed by Collado-Mateo et al. showed that whole body vibration could be an adequate
treatment for fibromyalgia, improving balance, disability index and health related to quality
of life as well as positively affecting fatigue and pain. [53] To our knowledge, this study is
the only one that compares the quality of life with the usage of vibration during orthodontic
treatment. To assess psychosocial impacts as well as the possible factors that could contribute
to improve the overall experience of the patients during treatment, further studies with larger
sample sizes are needed.

It is well known that the orthodontic tooth movement is a metabolic event featuring a
combination of bone resorption on the compression side and bone apposition on the tension
side. This alteration in the alveolar bone turnover is usually clinically associated with
increased tooth mobility. In 2011, Liou et al. published an article in which they assessed the
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postoperative changes in bone metabolism after orthognathic surgery and the corresponding
responses in the dentoalveolus, such as the changes in tooth mobility. [48] In their 4 months’
postoperative evaluation, one of the main findings included an increase tooth mobility
between the first week and third month follow-up appointment, coinciding with the results
appreciated in our research. Indeed, the mobility values obtained during our three-month
trial showed an overall increase in mobility when an orthodontic force was applied, the
highest increase in mobility being appreciated between T0 and T1, at the level of the
incisors. However, no statistically significant difference was found between the fixed
appliances only group and the group applying vibrational force daily. To our knowledge,
this is the first study assessing the amount of mobility change during tooth movement.
Consequently, considering the small sample size, it would be of rudimental importance to
perform more research on the subject including a much bigger sample size before drawing
any conclusions.

Proinflammatory cytokines have successfully demonstrated to comprise an important role
during remodeling of the alveolar bone by regulating the inflammatory process during
orthodontic tooth movement. There has been a recent increase in research interest in this
field to try to fully elucidate the process of tooth movement. Rats [25] and humans [26]
research focusing on Tumor Necrosis Factor alpha (TNF-α) and interleukins concentration
have shown increased values when orthodontic force was applied. In our research, TNF-α
concentration was found to be below the limits of detection in all samples. The discrepancy
in this finding could be however explained by the fact that different methods of collection
were used, Basaran et al. using gingival crevicular fluid instead of saliva. This difference in
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the protocol could affect some biomarker detection, especially ones found to be expressed in
lower concentrations in the GCF.

In a study performed in 2007, Ren et al. measured a panel of proinflammatory cytokines (IL1β, IL-6, IL-8 and TNF-α) during tooth movement of short and long durations and found
large variation in the results for each biomarker [27]. They found statistically significant
increased levels of IL-1β, IL-6 and TNF-α in the GCF 24h post-force application however
these values were slowly subsiding and returning to baseline levels by the end for the month.
On the other hand, they found a different trend in the concentration of IL-8 in the long-term,
where it reached a significant elevation in GCF after 1 month of tooth alignment, eventually
decreasing back to the baseline values at 2 months. Similar results were found by Lee et al.
in a study performed on Wistar rats where they concluded that the application of an
orthodontic force lead to a significant increase in IL-1β in pressure side gingiva on day 7 and
14 [28]. Regarding our findings, because of the small sample size, it is difficult to identify
and confirm possible trends. While the IL-1 β showed wide variability in the concentrations,
the IL-8 results tend to decrease expression after 1 month, later increasing at the 3rd month
time point. Comparing both groups together, we also found no statistically significant
differences in regard to proinflammatory cytokine levels when a vibration device was used
compared to the fixed appliance only group. It however needs to be kept in mind that factors
such as the circadian rhythm and the presence of oral inflammation have been shown to have
an effect on cytokine expression. [54] To our knowledge, this study is the first one to
evaluate the proinflammatory cytokines while applying vibration to tooth movement, which
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demonstrate the need of more research in this field. Furthermore, due to the small sample
size, it is too early draw any definitive conclusions on the subject.
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Chapter VI: Conclusion
1. There was no statistically significant difference in the expression of biological markers of
bone remodeling between the Acceledent and the control group.

2. There was no difference in the degree of tooth mobility in patients undergoing combined
vibration-fixed appliance treatment compared to orthodontic treatment alone.

3. The application of vibration to the dentition during orthodontic treatment did not show
greater changes in the irregularity index at any time point during the study.

4. The difference in the level of pain and Oral Health and Quality of Life was not
statistically significant in patients undergoing combined-treatment with a vibration
appliance compared to controls.
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FIGURES

Figure 1. Pain Diary
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Figure 2. Consort flow diagram for patient participation
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Figure 3. Salivary IL-1B expression
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Figure 4. Salivary IL-8 expression
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Figure 5. Pain Dairy Score
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TABLES
Table I. Irregularity index at each time points

T0
T1
T2
T3

Acceledent
Mean
8.61
5.29
2.96
1.23

SD
3.92
4.02
1.98
1.41

Control
Mean
9.10
5.88
2.88
0.85

SD
3.41
2.54
1.15
0.72

P value
0.817
0.763
0.934
0.544

Table II. Irregularity changes between each time points

T0-T1
T1-T2
T2-T3
T0-T3

Acceledent
Mean
3.32
2.33
1.73
7.38

SD
1.29
2.61
1.84
4.43

Control
Mean
3.22
2.99
2.04
8.25

SD
1.59
2.40
0.84
3.79

P value
0.900
0.643
0.716
0.713

Table III. Pain scores in the experimental and control groups (%)

T0
T1
T2

Acceledent
Mean
40.94
16.92
28.28

SD
28.18
22.20
24.62

Control
Mean
34.37
14.00
40.96

SD
14.16
16.33
22.25

P value
0.775
0.685
0.100
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Table IV. Periotest values changes between each time points (incisors)

T1-T0
T2-T1
T3-T2
T3-T0

Acceledent
Mean
7.84
-4.11
-0.16
3.56

SD
6.72
3.37
4.19
4.41

Control
Mean
2.84
-0.29
1.92
4.48

SD
4.67
4.91
2.50
3.65

P value
0.132
0.115
0.281
0.681

Table V. Periotest values changes between each time points (canines)

T1-T0
T2-T1
T3-T2
T3-T0

Acceledent
Mean
2.60
-0.49
1.52
3.62

SD
1.04
1.53
1.61
2.58

Control
Mean
2.67
-0.64
0.94
2.97

SD
1.66
1.41
2.01
1.75

P value
0.931
0.859
0.566
0.591

Table VI. Periotest values changes between each time points (premolars)

T1-T0
T2-T1
T3-T2
T3-T0

Acceledent
Mean
1.28
-0.28
0.08
1.09

SD
1.37
2.81
1.37
2.47

Control
Mean
0.35
0.83
0.24
1.42

SD
1.51
1.47
1.81
1.73

P value
0.254
0.373
0.863
0.775
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Table VII. Oral Health Quality of Life scores

T0
T1

Acceledent
Mean
5.24
5.50

T2
T3

4.40
3.18

SD
4.96
3.27

Control
Mean
7.33
7.27

SD
4.06
3.26

0.225
0.565

4.19
2.79

5.52
4.71

3.30
2.88

0.406
0.565

SD
156.26
87.21

0.406
0.749
0.749
0.749

P value

Table VIII. IL-1B salivary expression

T0
T1

Acceledent
Mean
41.72
26.97

SD
33.32
10.84

Control
Mean
81.85
56.62

T2
T3

29.57
26.98

27.75
22.92

107.98
132.73

208.04
205.01

SD
304.87
181.22

0.848
0.406

262.95
260.50

0.949
0.655

P value

Table IX. IL-8 salivary expression

T0
T1

Acceledent
Mean
267.80
189.65

SD
244.60
99.29

Control
Mean
249.49
176.12

T2
T3

197.06
299.11

114.16
122.12

260.59
384.32

P value
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